Skip to content

Clinical study of Xiao Cuo Yu Rong Prescription in treatment of moderate and severe acne

Clinical study of Xiao Cuo Yu Rong Prescription in treatment of moderate and severe acne

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2022000071
Enrollment
Unknown
Registered
2022-06-29
Start date
2022-08-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne

Interventions

Control group:Tanshinone capsules, 3 times a day, 15 minutes after meals, 4 capsules each time.
Treatment group:Xiaocuo Yurong decoction was taken orally, twice a day, 15 minutes after meals, 200ml each time.

Sponsors

Guang'anmen Hospital, Chinese Academy of traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: (1) Acne patients aged 18-40 in outpatient service; (2) Those who sign the informed consent form; (3) The severity of skin lesions was grade II ~ IV.

Exclusion criteria

Exclusion criteria: (1) Infection, pregnancy, childbirth, trauma and other stress states; (2) Those who have used retinoids and other external drugs or laser therapy within 2 weeks; Those who have received oral therapy within 4 weeks; (3) Patients with severe primary, immune and systemic diseases; (4) Those who are participating in other drug clinical trials or have participated in other clinical trials within one month; (5) Have ever had systemic or local contact allergy to any traditional Chinese medicine or matrix component in the drug; (6) The severity of skin lesions is grade I (mild).

Design outcomes

Primary

MeasureTime frame
Skin damage points;

Countries

CHINA

Contacts

Public ContactLi Guangrui
Drlgr999@163.com13718671918

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026